Elsevier

Progress in Neurobiology

Volume 51, Issue 3, February 1997, Pages 337-361
Progress in Neurobiology

THE γ-HYDROXYBUTYRATE SIGNALLING SYSTEM IN BRAIN: ORGANIZATION AND FUNCTIONAL IMPLICATIONS

https://doi.org/10.1016/S0301-0082(96)00064-0Get rights and content

Abstract

γ-Hydroxybutyrate is a metabolite of GABA which is synthesized and accumulated by neurons in brain. This substance is present in micromolar quantities in all brain regions investigated as well as in several peripheral organs. Neuronal depolarization releases γ-hydroxybutyrate into the extracellular space in a Ca2+-dependent manner. Gamma-hydroxybutyrate high-affinity receptors are present only in neurons, with a restricted specific distribution in the hippocampus, cortex and dopaminergic structures of rat brain (the striatum in general, olfactory bulbs and tubercles, frontal cortex, dopaminergic nuclei A9, A10 and A12). Stimulation of these receptors with low amounts of γ-hydroxybutyrate induces in general hyperpolarizations in dopaminergic structures with a reduction of dopamine release. However, in the hippocampus and the frontal cortex, it seems that γ-hydroxybutyrate induces depolarization with an accumulation of cGMP and an increase in inositol phosphate turnover. Some of the electrophysiological effects of GHB are blocked by NCS-382, a γ-hydroxybutyrate receptor antagonist while some others are strongly attenuated by GABAB receptors antagonists.

Gamma-hydroxybutyrate penetrates freely into the brain when administered intravenously or intraperitoneally. This is a unique situation for a molecule with signalling properties in the brain. Thus, the γ-hydroxybutyrate concentration in brain easily can be increased more than 100 times. Under these conditions, γ-hydroxybutyrate receptors are saturated and probably desensitized and down-regulated. It is unlikely that GABAB receptors could be stimulated directly by GHB. Most probably, GABA is released in part under the control of GHB receptors in specific pathways expressing GABAB receptors. Alternatively, GABAB receptors might be specifically stimulated by the GABA formed via the metabolism of γ-hydroxybutyrate in brain. In animals and man, these GHBergic and GABAergic potentiations induce dopaminergic hyperactivity (which follows the first phase of dopaminergic terminal hyperpolarization), a strong sedation with anaesthesia and some EEG changes with epileptic spikes. It is presumed that, under pathological conditions (hepatic failure, alcoholic intoxication, succinic semialdehyde dehydrogenase defects), the rate of GHB synthesis or degradation in the peripheral organ is modified and induces increased GHB levels which could interfere with the normal brain mechanisms. This pathological status could benefit from treatments with γ-hydroxybutyric and/or GABAB receptors antagonists. Nevertheless, the regulating properties of the endogenous γ-hydroxybutyrate system on the dopaminergic pathways are a cause for the recent interest in synthetic ligands acting specifically at γ-hydroxybutyrate receptors and devoid of any role as metabolic precursor of GABA in brain. © 1997 Elsevier Science Ltd. All Rights Reserved.

Section snippets

INTRODUCTION

Since the early sixties, γ-hydroxybutyrate generally has been thought to be a drug which enters the brain easily and which possesses the general profile of a GABAergic ligand (Laborit, 1964). Up to now, the majority of the research devoted to this compound has focused on the neuropharmacological and neurophysiological aspects of systemic administration. However, GHB is primarily a naturally occurring substance in brain which was identified about 30 years ago and which is synthesized locally (

γ-Hydroxybutyrate is Present in Small Quantities in Mammalian Brain

γ-Hydroxybutyrate real concentration in brain has been a matter of debate because it needs gas chromatography with preferably mass spectrometric detection to measure actual levels (Doherty et al. (1975a), Doherty et al. (1978); Ehrhardt et al., 1988). In addition, endogenous GHB concentrations fluctuate rapidly in the ischaemic brain, so that brain dissection must be carried out rapidly after death (Snead and Morley, 1981; Eli and Cattabeni, 1983; Vayer et al., 1988). The lowest levels of GHB

The γ-Hydroxybutyrate Model of Generalized Absence Seizures in Rodents

The potentiation of the GHB system by administration of low (10–100 mg/kg) or higher (200–400 mg/kg) doses of GHB or GBL induces in most of the animal species studied (chick, cat, rabbit, rat, dog, mice) and also in man, a modification of behaviour and of the EEG trace (Winters and Spooner, 1965; Yamada et al., 1967; Metcalf et al., 1966; Godschalk et al., 1977; Godbout and Pivik (1982), Snead (1984a), Snead (1988), Snead (1992); Brankack et al., 1993). Low doses of GHB cause a rise in states

CONCLUSION

There is little doubt that GHB represents a neuromodulatory signal in brain with a specific organization constituted by GHBergic pathways mainly localized in the rostral part of the brain. Molecular cloning of receptor(s) and enzymes which are part of these pathways will confirm this concept and further clarify the functional role of GHB in brain. One of the main distinctive properties of this system is that the simple hydrocarbon chain of GHB penetrates the brain with no apparent control when

Acknowledgements

This work was supported by grant from DRET 93-172.

References (236)

  • G. Colombo et al.

    Blockade of the discriminative stimulus effects of γ-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382

    Physiol. Behav.

    (1995)
  • G. Colombo et al.

    Cross-tolerance to ethanol and gamma-hydroxybutyric acid

    Eur. J. Pharmacol.

    (1995)
  • G. Crosby et al.

    Naloxone pretreatment alters the local cerebral metabolic effect of γ-hydroxybutyrate in rats

    Brain Res.

    (1983)
  • V. Crunelli et al.

    A role of GABAB receptors in excitation and inhibition of thalamocortical cells

    Trends Neurosci.

    (1991)
  • A. Depaulis et al.

    Effects of gamma-hydroxybutyrate and gamma-butyrolactone derivatives on spontaneous generalized non-convulsive seizures in the rat

    Neuropharmacology

    (1988)
  • A. Depaulis et al.

    Suppressive effects of intranigral injection of muscimol in three models of generalized nonconvulsive epilepsy induced by chemical agents

    Brain Res.

    (1989)
  • P. Devoto et al.

    Naloxone antagonizes ethanol — but not gamma-hydroxybutyrate-induced sleep in mice

    Eur. J. Pharmacol.

    (1994)
  • M. Diana et al.

    Low doses of γ-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats

    Brain Res.

    (1991)
  • M. Diana et al.

    Heterogeneous responses of substantia nigra pars reticulata neurons to γ-hydroxybutyric acid administration

    Eur. J. Pharmacol.

    (1993)
  • M. Diana et al.

    Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence

    Neuroscience

    (1996)
  • R. Dingledine et al.

    Naloxone as a GABA antagonist: evidence from iontophoretic receptor binding and convulsant studies

    Eur. J. Pharmacol.

    (1978)
  • P. Divry et al.

    A new patient with 4-hydroxybutyric aciduria, a possible defect of 4-aminobutyrate metabolism

    Clin. Chim. Acta

    (1983)
  • J.D. Doherty et al.

    A sensitive method for quantitation of γ-hydroxybutyric acid and γ-butyrolactone in brain by electron capture gas chromatography

    Anal. Biochem.

    (1975)
  • W.N. Fishbein et al.

    Purification and properties of an enzyme in human blood and rat liver microsomes catalyzing the formation and hydrolysis of γ-lactones

    J. Biol. Chem.

    (1966)
  • L. Gallimberti et al.

    Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome

    Lancet

    (1989)
  • G.L. Gessa et al.

    Selective increase of brain dopamine induced by gamma hydroxybutyrate

    Life Sci.

    (1966)
  • K.M. Gibson et al.

    Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiency

    Lancet

    (1989)
  • S. Gobaille et al.

    Characterization of methionine-enkephalin release in the rat striatum by in vivo dialysis: effects of gamma-hydroxybutyrate on cellular and extracellular methionine-enkephalin levels

    Neuroscience

    (1994)
  • R. Godbout et al.

    EEG and behavioral effects of gamma-hydroxybutyrate in the rabbit

    Life Sci.

    (1982)
  • R. Godbout et al.

    Effect of gamma-hydroxybutyrate and its antagonist NSC-382 on spontaneous cell firing in the prefrontal cortex of the rat

    Brain Res.

    (1995)
  • M. Godschalk et al.

    Slow wave sleep and a state resembling absence epilepsy induced in the rat by γ-hydroxybutyrate

    Eur. J. Pharmacol.

    (1977)
  • M. Godschalk et al.

    Antagonism of γ-hydroxybutyrate induced hypersynchronisation in the EEG of the rat by anti-petit mal drugs

    Neurosci. Lett.

    (1976)
  • A. Handforth et al.

    Inhibition by dopamine agonists of dopamine accumulation following hydroxybutyrate treatment

    Eur. J. Pharmacol.

    (1975)
  • N.C. Harris et al.

    The effects of gamma-hydroxybutyrate on the membrane properties of guineapig pars compacta neurons in the substantia nigra in vitro

    Neuroscience

    (1989)
  • N. Haykal-Coates et al.

    Pargyline and γ-butyrolactone enhance tyrosine hydroxylase immunostaining of nigrostriatal axons

    Brain Res.

    (1991)
  • W.G. Hearl et al.

    A mitochondrial NADP+-dependent reductase related to the 4-aminobutyrate shunt

    J. Biol. Chem.

    (1985)
  • V. Hechler et al.

    Localization studies of γ-hydroxybutyrate receptors in rat striatum and hippocampus

    Brain Res. Bull.

    (1989)
  • V. Hechler et al.

    Selective distribution pattern of γ-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography

    Brain Res.

    (1992)
  • V. Hechler et al.

    Trans-gamma-hydroxycrotonic acid binding sites in brain: evidence for a subpopulation of gamma-hydroxybutyrate sites

    Neurosci. Lett.

    (1990)
  • L. Hösli et al.

    Action of γ-hydroxybutyrate and GABA on neurones of cultured rat central nervous system

    Neurosci. Lett.

    (1983)
  • G.K. Aghajanian et al.

    γ-Hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy

    J. Pharmacol. Expl Ther.

    (1970)
  • A.A. Artru et al.

    Gamma-hydroxybutyrate: cerebral metabolic, vascular, and protective effects

    J. Neurochem.

    (1980)
  • P.K. Banerjee et al.

    Presynaptic gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB (GABAB) receptor-mediated release of GABA and glutamate (GLU) in rat thalamic ventrobasal nucleus (VB): a possible mechanism for the generation of absence-like seizures induced by GHB

    J. Pharmacol. Expl Ther.

    (1995)
  • M.A. Bedard et al.

    Nocturnal gamma-hydroxybutyrate. Effect on periodic leg movements and sleep organization of narcoleptic patients

    Clin. Neuropharmacol.

    (1989)
  • J. Benavides et al.

    A high-affinity, Na+-dependent uptake system for γ-hydroxybutyrate in membrane vesicles prepared from rat brain

    J. Neurochem.

    (1982)
  • R. Bernasconi et al.

    Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors

    J. Neural Transm.

    (1992)
  • R. Bernasconi et al.

    The use of inhibitors of GABA-transaminase for the determination of GABA turnover in mouse brain regions: an evaluation of aminooxyacetic acid and gabaculine

    J. Neurochem.

    (1982)
  • S.P. Bessman et al.

    Gamma-hydroxybutyrate, a normal brain metabolite

    Nature

    (1963)
  • G. Biggio et al.

    Suppression of voluntary alcohol intake in rats and alcoholics by gamma-hydroxybutyric acid: a non-GABAergic mechanism

    Adv. Biochem. Psychopharmacol.

    (1992)
  • M. Bloch-Tardy et al.

    Two forms of GABA-T in pig brain. Purification and properties

    Neurochem. Res.

    (1980)
  • Cited by (0)

    *

    Tel.: 03-88-45-66-38; Fax: 03-88-45-66-05; E-mail: [email protected].

    View full text